David Newman

David Newman has extensive experience in the pharmaceutical industry. David is currently the Vice President of Anti-Fungal Marketing at Melinta Therapeutics. Prior to this, they held leadership positions at Cidara Therapeutics, MNG Health, Mallinckrodt Pharmaceuticals, IKARIA (now part of Mallinckrodt Pharmaceuticals), GlaxoSmithKline Pharma GmbH, and SmithKline Beecham Corporation. Throughout their career, David has demonstrated expertise in marketing, commercial operations, business development, and product management. David'sroles have involved leading teams, developing marketing strategies, and driving business growth in the healthcare sector.

David Newman has a Master of Business Administration (MBA) degree in Marketing from San Diego State University. David also holds a Certificate in California Naturalist from the University of California, Agriculture and Natural Resources. The start and end years for both of these educational experiences are not provided.